Free Trial

TerrAscend (OTCMKTS:TSNDF) Releases Quarterly Earnings Results, Beats Expectations By $0.04 EPS

TerrAscend logo with Medical background
Remove Ads

TerrAscend (OTCMKTS:TSNDF - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.03) by $0.04, Zacks reports. The firm had revenue of $74.35 million during the quarter, compared to analyst estimates of $72.37 million. TerrAscend had a negative net margin of 23.95% and a negative return on equity of 31.48%.

TerrAscend Trading Up 13.7 %

Shares of OTCMKTS:TSNDF traded up $0.06 during trading on Monday, hitting $0.47. The stock had a trading volume of 862,414 shares, compared to its average volume of 388,003. The company has a current ratio of 1.35, a quick ratio of 0.69 and a debt-to-equity ratio of 0.81. TerrAscend has a 12-month low of $0.38 and a 12-month high of $2.20. The stock has a 50-day simple moving average of $0.57 and a two-hundred day simple moving average of $0.85.

Wall Street Analyst Weigh In

Separately, Atb Cap Markets downgraded shares of TerrAscend from a "strong-buy" rating to a "hold" rating in a research note on Monday, December 9th.

Get Our Latest Stock Analysis on TSNDF

TerrAscend Company Profile

(Get Free Report)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names.

See Also

Earnings History for TerrAscend (OTCMKTS:TSNDF)

Should You Invest $1,000 in TerrAscend Right Now?

Before you consider TerrAscend, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TerrAscend wasn't on the list.

While TerrAscend currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Will Tesla’s Robot Future Save Its Falling Stock?
NVIDIA’s Dip Is a Gift—Here’s Why It Won’t Last
Best ETFs for Spring 2025: Strong and Steady Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads